ARQT · Company research
Arcutis Biotherapeutics, Inc. Common Stock (ARQT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 23.92 | $3,482,505.8 | -30638494.20 | — | — | — | 0.03304147896544526462 | 0.01578802061846322633 | 0.27902458136367278263 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.